Abstract
Invasive aspergillosis (IA) is common in allogeneic SCT recipients, with an incidence of 4–10%. The majority of these infections are diagnosed several months after SCT and they are frequently associated with GVHD. The diagnosis is difficult and often delayed. Established IA is notoriously difficult to treat with a death rate of 80–90%. This review summarises recent data on this problem to assess whether there has been any progress. Effective prophylactic measures are still lacking. Severe immunosuppression is the main obstacle to the success of therapy. Recent and ongoing developments in diagnostic measures and new antifungal agents may improve treatment results to some extent, but Aspergillus infections still remain a formidable problem in allogeneic transplantation. Further studies in this field will focus on the role of various cytokines and combinations of antifungal agents.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
de Bock R . Epidemiology of invasive fungal infection in bone marrow transplantation Bone Marrow Transplant 1994 14: (Suppl. 5) S1 S2
Jantunen E, Ruutu P, Niskanen L et al. Incidence and risk factors of invasive fungal infections in allogeneic BMT recipients Bone Marrow Transplant 1997 19: 801 808
Wald A, Leisenring W, Burik J-A, Bowden RA . Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation J Infect Dis 1997 175: 1459 1466
Marr KA, Carter RA, Crippa F et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients Clin Infect Dis 2002 34: 909 917
McWhinney PHM, Kibbler CC, Hamon MD et al. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years’ experience Clin Infect Dis 1993 17: 397 404
Saugier-Veber P, Devergie A, Sulahian A et al. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant recipients: results of a 5-year retrospective study Bone Marrow Transplant 1993 12: 121 124
Morrison VA, Haake RJ, Weisdorf DJ . Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome Am J Med 1994 96: 497 503
Hovi L, Saarinen-Pihkala UM, Vettenranta K, Saxen H . Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years Bone Marrow Transplant 2000 26: 999 1004
Baddley JW, Stroud TP, Salzman D, Pappas PG . Invasive mold infections in allogeneic bone marrow transplant recipients Clin Infect Dis 2001 32: 1319 1324
Jantunen E, Piilonen A, Volin L et al. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients Bone Marrow Transplant 2000 25: 867 871
Paterson DL, Singh N . Invasive aspergillosis in transplant recipients Medicine 1999 78: 123 138
Offner F, Cordonnier C, Ljungman P et al. Impact of previous aspergillosis on the outcome of bone marrow transplantation Clin Infect Dis 1998 26: 1098 1103
Denning DW . Invasive aspergillosis Clin Infect Dis 1998 26: 781 805
Reichenberger F, Habicht J, Matt P et al. Diagnostic yield of bronchoscopy in histologically proven pulmonary aspergillosis Bone Marrow Transplant 1999 24: 1195 1199
Caillot D, Casanovas PO, Bernard A et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery J Clin Oncol 1997 15: 139 147
Jantunen E, Piilonen A, Volin L et al. Radiologically guided fine needle lung biopsies in the evaluation of focal pulmonary lesions in allogeneic stem cell transplant recipients Bone Marrow Transplant 2002 29: 353 356
Bretagne S, Costa J-M, Bart-Delabasse A et al. Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis Clin Infect Dis 1998 26: 1407 1412
Machetti M, Feasi M, Mordini N et al. Comparison of an enzyme immunoassay and a latex agglutination system for diagnosis of invasive aspergillosis in bone marrow transplant recipients Bone Marrow Transplant 1998 21: 917 921
Maertens J, Verhaegen J, Demuynck D et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis J Clin Microbiol 1999 37: 3223 3228
Sulahian A, Boutboul F, Ribaud P et al. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and one pediatric hematology units during a 4-year prospective study Cancer 2001 91: 311 318
Maertens J, Verhaegen J, Lagrou K et al. Screening for circulating galactomannan as a non-invasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation Blood 2001 97: 1604 1610
Bretagne S, Costa JM, Marmoral KM et al. Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR J Clin Microbiol 1995 33: 1164 1168
Einsele H, Quabeck K, Muller K-D . Prediction of invasive pulmonary aspergillosis from colonization of lower respiratory tract before marrow transplantation Lancet 1998 352: 1443
Einsele H, Hebart H, Roller G et al. Detection and identification of fungal pathogens in blood by using molecular probes J Clin Microbiol 1997 35: 1353 1360
van Burik J-A, Myerson D, Schreckhise RW, Bowden RA . Panfungal PCR assay for detection of fungal infection in human blood specimen J Clin Microbiol 1998 36: 1169 1175
Hebart H, Loffler J, Meisner C et al. Early detection of Aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening J Infect Dis 2000 181: 1713 1719
Williamson ECM, Leeming JP, Palmer HM et al. Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction Br J Haematol 2000 108: 132 139
Ellis M, Spence D, de Pauw B et al. An EORTC international multicenter trial (EORTC number 19923) comparing two doses of liposomal amphotericin B for treatment of invasive aspergillosis Clin Infect Dis 1998 27: 1406 1412
Leenders ACAP, Daenen S, Jansen RLH et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections Br J Haematol 1998 103: 205 212
Walsh TJ, Finberg RW, Arndt C et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia New Engl J Med 1999 340: 764 771
Herbrecht R, Auvrignon A, Andres E et al. Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients Eur J Clin Microbiol Infect Dis 2001 20: 77 82
Mehta J, Kelsey S, Chu P et al. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies Bone Marrow Transplant 1997 20: 39 43
Wingard JR . Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses Bone Marrow Transplant 1997 19: 343 347
Walsh TJ, Hiemenz JW, Seibel NL et al. Amphotericin B lipid complex for invasive fungal infections: analysis on safety and efficacy in 556 cases Clin Infect Dis 1998 26: 1383 1396
White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis Clin Infect Dis 1997 24: 635 642
Noskin G, Pietrelli L, Gurwith M, Bowden R . Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients Bone Marrow Transplant 1999 23: 697 703
Wingard JR, White M, Anaissie E et al. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia Clin Infect Dis 2000 31: 1155 1163
Denning DW, Lee JY, Hostetler JS et al. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy of invasive pulmonary aspergillosis Am J Med 1994 97: 135 144
Foot ABM, Veys PA, Gibson BES . Itraconazole oral solution as antifungal prophylaxis in children undergoing stem cell transplantation or intensive chemotherapy for haematological disorders Bone Marrow Transplant 1999 24: 1089 1093
Winston DJ, Maziarz RT, Chandrasekar PH et al. Long-term antifungal prophylaxis in allogeneic bone marrow transplant patients: a multicenter, randomized trial of intravenous/oral itraconazole versus intravenous/oral fluconazole Blood 2001 98: 479a (abstr.)
Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis New Engl J Med 2002 347: 408 415
Denning DW, Ribaud P, Milpied N et al. Efficacy and safety of voriconazole in the treatment of invasive aspergillosis Clin Infect Dis 2002 34: 563 571
Keating GM, Jarvis B . Caspofungin Drugs 2001 61: 1121 1129
Maertens J, Raad I, Sable CA et al. Multicenter, noncomparative study to evaluate safety and efficacy of caspofungin (CAS) in adults with invasive aspergillosis (IA) refractory or intolerant to amphotericin B (AMB), AMB lipid formulations (lipid AMB), or azoles. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy p 370 poster 1103, Toronto 2000
Rex JH, Bennett JE, Gallin JI et al. In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae J Infect Dis 1991 163: 649 852
Reichenberger F, Habicht J, Kaim A et al. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases Am J Respir Crit Care Med 1998 158: 885 890
Salerno CT, Ouyang DW, Pederson TS et al. Surgical therapy for pulmonary aspergillosis in immunocompromised patients Ann Thorac Surg 1998 65: 1415 1419
Yeghen T, Kibbler CC, Prentice HG et al. Management of invasive aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution Clin Infect Dis 2000 31: 859 868
Kennedy CA, Adams GL, Neglia JP, Giebink GS . Impact of surgical treatment on paranasal fungal infections in bone marrow transplant patients Otolaryngol Head Neck Surg 1997 116: 610 616
Denning DW . Therapeutic outcome of invasive aspergillosis Clin Infect Dis 1996 23: 608 615
Ribaud P, Chastang C, Latge J-P et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation Clin Infect Dis 1999 28: 322 330
Jantunen E, Ruutu P, Piilonen A et al. Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients Bone Marrow Transplant 2000 26: 759 762
Hagensee ME, Bauwens JE, Kjos B, Bowden RA . Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984–1992 Clin Infect Dis 1994 19: 402 408
Schwartz S, Behre G, Heinemann V et al. Aerosolized amphotericin B inhalations as prophylaxis of invasive Aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial Blood 1999 93: 3654 3661
Morgenstern GR, Prentice AG, Prentice HG et al. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies Br J Haematol 1999 105: 901 911
Sherertz RJ, Belani A, Krames BS et al. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients Am J Med 1987 83: 709 718
Hertenstein B, Kern WV, Schmeiser T et al. Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia Ann Hematol 1994 68: 21 26
Wingard JR . Fungal infections after bone marrow transplant Biol Blood Marrow Transplant 1999 5: 55 68
Tollemar J, Ringden O, Andersson S et al. Randomized double-blind study of liposomal amphotericin B (AmBisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients Bone Marrow Transplant 1993 12: 577 582
Ruutu T, Volin L, Parkkali T et al. Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study Blood 2000 96: 2391 2398
Heslop H . Haemopoietic stem cell transplantation from unrelated donors Br J Haematol 1999 105: 2 6
Aversa F, Tabilio A, Velardi A et al. Treatment of high-risk acute leukemia with T-cell depleted stem cells from related donors with one fully mismatched HLA haplotype New Engl J Med 1998 339: 1186 1193
Carella AM, Champlin R, Slavin S et al. Mini-allografts: ongoing trials in humans Bone Marrow Transplant 2000 25: 345 350
Junghans C, Marr KA, Carter RA et al. Incidence of bacterial and fungal infections after nonmyeloablative compared to myeloablative allogeneic hematopoietic stem cell transplantation (HSCT) Blood 2001 98: 479a (Abstr.)
Grazziutti M, Przepiorka D, Rex JH et al. Dendritic cell-mediated stimulation of the in vitro lymphocyte response to Aspergillus Bone Marrow Transplant 2001 27: 647 652
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jantunen, E., Anttila, VJ. & Ruutu, T. Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?. Bone Marrow Transplant 30, 925–929 (2002). https://doi.org/10.1038/sj.bmt.1703738
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703738
Keywords
This article is cited by
-
Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT
Bone Marrow Transplantation (2010)
-
IL1 Gene Cluster Polymorphisms and Its Haplotypes may Predict the Risk to Develop Invasive Pulmonary Aspergillosis and Modulate C-reactive Protein Level
Journal of Clinical Immunology (2008)
-
Feasibility and obstacles in home chemotherapy for malignant lymphoma
International Journal of Hematology (2007)
-
Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients
Bone Marrow Transplantation (2004)
-
Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation
Bone Marrow Transplantation (2004)